Australia - English - Department of Health (Therapeutic Goods Administration)

sun pharma anz pty ltd - valaciclovir, quantity: 500 mg - tablet, film coated - excipient ingredients: povidone; magnesium stearate; indigo carmine aluminium lake; crospovidone; microcrystalline cellulose; titanium dioxide; hypromellose; polysorbate 80; macrogol 6000; macrogol 400 - for the treatment of herpes zoster (shingles) in adult patients who commence therapy within 72 hours of the onset of rash. treatment of ophthalmic zoster. treatment of clinical episodes of genital herpes simplex infections. for the prevention of recurrent genital herpes in immunocompromised patients with creatinine clearance of > 15 ml/min. for the reduction of transmission of genital herpes in patients suffering from recurrent genital herpes. in addition to therapy with valaciclovir, it is recommended that patients use safer sex practices (see precautions). for prophylaxis of cytomegalovirus (cmv) infection and disease following solid organ transplantation in patients at risk of cmv disease.

Australia - English - Department of Health (Therapeutic Goods Administration)

sun pharma anz pty ltd - levothyroxine sodium, quantity: 0.075 mg - tablet - excipient ingredients: hyprolose; magnesium stearate; pregelatinised starch; microcrystalline cellulose; allura red ac aluminium lake; indigo carmine aluminium lake - levothyroxine sodium is indicated for the management of demonstrated thyroid hormone deficiency.,levothyroxine sodium is also used to suppress thyrotropin (tsh) for the management of tsh-responsive tumours of the thyroid.

Australia - English - Department of Health (Therapeutic Goods Administration)

sun pharma anz pty ltd - levothyroxine sodium, quantity: 0.2 mg - tablet - excipient ingredients: magnesium stearate; pregelatinised starch; microcrystalline cellulose; hyprolose; allura red ac aluminium lake - levothyroxine sodium is indicated for the management of demonstrated thyroid hormone deficiency.,levothyroxine sodium is also used to suppress thyrotropin (tsh) for the management of tsh-responsive tumours of the thyroid.

Australia - English - Department of Health (Therapeutic Goods Administration)

sun pharma anz pty ltd - levothyroxine sodium, quantity: 0.05 mg - tablet - excipient ingredients: pregelatinised starch; magnesium stearate; hyprolose; microcrystalline cellulose; titanium dioxide; indigo carmine aluminium lake - levothyroxine sodium is indicated for the management of demonstrated thyroid hormone deficiency.,levothyroxine sodium is also used to suppress thyrotropin (tsh) for the management of tsh-responsive tumours of the thyroid.

Australia - English - Department of Health (Therapeutic Goods Administration)

sun pharma anz pty ltd - fluconazole, quantity: 150 mg - capsule, hard - excipient ingredients: gelatin; colloidal anhydrous silica; maize starch; titanium dioxide; lactose monohydrate; magnesium stearate; purified water; sodium lauryl sulfate; patent blue v; propylene glycol; butan-1-ol; isopropyl alcohol; ethanol; shellac; strong ammonia solution; iron oxide black; potassium hydroxide - for the treatment of vaginal candidiasis, when topical therapy has failed.

Australia - English - Department of Health (Therapeutic Goods Administration)

sun pharma anz pty ltd - ciclosporin, quantity: 900 microgram/ml - eye drops - excipient ingredients: peg-40 hydrogenated castor oil; octoxinol 40; monobasic sodium phosphate dihydrate; dibasic sodium phosphate; sodium chloride; povidone; water for injections; hydrochloric acid; sodium hydroxide - cequa is indicated to increase tear production in patients with moderate to severe keratoconjunctivitis sicca (dry eye) where prior use of artificial tears has not been sufficient.

Australia - English - Department of Health (Therapeutic Goods Administration)

sun pharma anz pty ltd - sertraline hydrochloride, quantity: 111.92 mg (equivalent: sertraline, qty 100 mg) - tablet, film coated - excipient ingredients: microcrystalline cellulose; calcium hydrogen phosphate dihydrate; sodium starch glycollate; hyprolose; magnesium stearate; titanium dioxide; hypromellose; purified talc; macrogol 400 - adults: setrona is indicated for the treatment of major depression. setrona is indicated for the treatment of premenstrual dysphoric disorder (pmdd) as defined by dsm-iv criteria.

Australia - English - Department of Health (Therapeutic Goods Administration)

sun pharma anz pty ltd - sertraline hydrochloride, quantity: 55.96 mg (equivalent: sertraline, qty 50 mg) - tablet, film coated - excipient ingredients: microcrystalline cellulose; calcium hydrogen phosphate dihydrate; sodium starch glycollate; hyprolose; magnesium stearate; titanium dioxide; hypromellose; purified talc; macrogol 400 - adults: setrona is indicated for the treatment of major depression. setrona is indicated for the treatment of premenstrual dysphoric disorder (pmdd) as defined by dsm-iv criteria.

Australia - English - Department of Health (Therapeutic Goods Administration)

sun pharma anz pty ltd - epoprostenol sodium, quantity: 0.531 mg (equivalent: epoprostenol, qty 0.5 mg) - injection, powder for - excipient ingredients: sucrose; sodium hydroxide; glycine - epoprostenol sun is indicated for the long-term treatment, via continuous intravenous infusion, in who functional class iii or class iv patients with idiopathic pulmonary arterial hypertension, familial pulmonary arterial hypertension and pulmonary arterial hypertension associated with the scleroderma spectrum of diseases.

Australia - English - Department of Health (Therapeutic Goods Administration)

sun pharma anz pty ltd - levetiracetam, quantity: 100 mg/ml - injection, concentrated - excipient ingredients: glacial acetic acid; water for injections; sodium chloride; sodium acetate trihydrate - levetiracetam (film-coated tablets and oral solution) is indicated for:,? use in epileptic patients aged 4 years and older, initially as add on therapy, in the treatment of partial onset seizures with or without secondary generalisation, ? monotherapy in the treatment of partial onset seizures, with or without secondary generalisation, in patients from 16 years of age with newly diagnosed epilepsy. ? add on therapy in the treatment of myoclonic seizures in adults and adolescents from 12 years of age with juvenile myoclonic epilepsy (jme),and ? add on therapy in the treatment of primary generalized tonic-clonic seizures in adults and children from 4 years of age with idiopathic generalized epilepsy (ige).,levetiracetam sun concentrated injection after dilution is an alternative for patients when oral administration is temporarily not feasible.